Home/Gensaic/Uyanga Tsedev, PhD

UT

Uyanga Tsedev, PhD

Chief Scientific Officer, Co-founder

Therapeutic Areas

Metabolic Diseases

Gensaic Pipeline

Drug	Indication	Phase
Novo Nordisk Collaboration Program(s)	Undisclosed Cardiometabolic Targets	Discovery

Leadership Team at Gensaic

Lavi Erisson, MD MBA

Chief Executive Officer, Co-founder & Board Member

Jonathan Hsu, PhD

Chief Technology Officer, Co-founder

Jeremy Levin, D.Phil, MB BChir

Chairman of the Board

Briggs Morrison, MD

View full Gensaic profile